For Debate: What do we really know about Autoantibody Abnormalities and Reproductive Failure: A Critical Review

References

• El-Roeiy A., Gleicher N. Definition of normal autoanti-body levels in an apparently healthy population. Obstet Gynecol 1988; 72: 596–602
   PubMed Web of Science ®Google Scholar
• Shoenteld Y., Isenberg D. The mosaic of autoimmunity. Research Monographs in Immunology. Elsevier. 1989; Volume 12
   Google Scholar
• Gleicher N., Harlow L., Zilberstein M. The regulatory effect of antiphospholipid antibodies (APA) on signal transduction: A possible model for autoantibody induced reproductive failure. Am J Obstet Gynecol 1992; 167: 637–642
   PubMed Web of Science ®Google Scholar
• Jerne N. K. Towards a network theory of the immune system. Am Immunol (Inst Pasteur) 1974; 125c: 373–389
   PubMedGoogle Scholar
• Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet, 1: 1361–1363
   PubMedGoogle Scholar
• Lubbe W. F., Butler W. S., Palmer S. J. Lupus anticoagulant in pregnancy. Brit J Obstet Gynaecol 1984; 91: 357–363
   PubMedGoogle Scholar
• Gleicher N., Friberg J. IgM gammopathy and the lupus anticoagulant suyndrome in habitual aborters. JAMA 1985; 253: 3278–3281
   PubMed Web of Science ®Google Scholar
• Branch D. W., Scott J. R., Kochenour N. K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322–1326
   PubMed Web of Science ®Google Scholar
• Gleicher N., El-Roeiy A., Confino E., Friberg J. Is endometriosis an autoimmune disease?. Obstet Gynecol 1987; 70: 115–122
   PubMed Web of Science ®Google Scholar
• Kennedy S. H., Nunn B., Cederhold-Williams S. A., Barlow D. H. Cardiolipin antibody levels in endometriosis and systemic lupus erythematosus. Fertil Steril 1989; 52: 1061–1062
   PubMedGoogle Scholar
• Confino E., Harlow L., Gleicher N. Peritoneal fluid and serum autoantibody levels in patients with endometriosis. Fertil Steril 1990; 52: 242–245
   Google Scholar
• Kilpatrick D. C., Haining R. E. B., Smith S. S.K. Are cardiolipin antibody levels elevated in endometriosis?. Fertil Steril 1991; 55: 436–437
   PubMedGoogle Scholar
• Taylor P. V., Maloney M. D., Campbell J. M., Skerrow S. M., Nip M. M. C., Parmar R., Tate G. Autoreactivity in women endometriosis. Br J Obstet Gynaecol 1991; 98: 680–685
   PubMedGoogle Scholar
• Gleicher N., El-Roeiy A., Confino E., Friberg J. Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989; 160: 1376–1385
   PubMed Web of Science ®Google Scholar
• Taylor P. V., Campbell J. M., Scott J. S. Presence of autoantibodies in women with unexplained infertility. Am J Obstet Gynecol 1989; 161: 377–379
   PubMed Web of Science ®Google Scholar
• El-Roeiy A., Valessini G., Friberg J., Shoenfeld V., Kennedy R. C., Tincani A., Balestrieri G., Gleicher N. Autoantibodies and common idiotypes in sperm antibody positive females and males. Am J Obstet Gynecol 1988; 158: 596–603
   PubMedGoogle Scholar
• El-Roeiy A., Myers S. A., Gleicher N. The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1991; 164: 1253–1261
   PubMed Web of Science ®Google Scholar
• Kajino T. Polyclonal activation of IgM antibodies to phospholipid in patients with idiopathic fetal growth retardation. Am J Reprod Immunol 1991; 25: 28–34
   PubMedGoogle Scholar
• Polzin W. J., Kopelman J. N., Robinson R. D., Read J. A., Brady K. The association by fetal growth retardation. Obstet Gynecol 1991; 78: 1108–1111
   PubMed Web of Science ®Google Scholar
• Branch D. W., Andres R., Digre K. B., Rote N. S., Scott J. R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73: 541–545
   PubMed Web of Science ®Google Scholar
• Gleicher N., Dudkiewicz A., Kaberlein G., Parrilli M., Pratt D. Premature ovarian failure is characterized by gammopathies, Submitted for publication
   Google Scholar
• Lubbe W. F., Walker E. B. Chorea gravidarum association with circulating lupus anticoagulant: Successful outcome of pregnancy with prednisone and aspirin therapy. Br J Obstet Gynaecol 1983; 90: 487–490
   PubMedGoogle Scholar
• El-Roeiy A., Gleicher N., Friberg J., Confino E., Dudkiewicz A. B. Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987; 70: 163–170
   PubMed Web of Science ®Google Scholar
• Grimmer D., Landas S., Kemp J. D. IgM antitrophoblast antibodies in a patient with a pregnancy-associated lupus-like disorder, vasculitis, and recurrent intrauterine fetal demise. Arch Pathol Lab Med 1988; 112: 191–193
   PubMed Web of Science ®Google Scholar
• Anonymous Editorial. Lupus anticoagulant. Lancet 1984; 1: 1361–1363
   Google Scholar
• Canosa R. T., Sise H. S. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol 1982; 13: 121–126
   PubMedGoogle Scholar
• Fulker S., Zarrabi M. H., Romano G. S., et al. IgM inhibitor of contact activation phase of coagulation disorders in chlorpromazine-treated patients. Ann Int Med 1979; 91: 194–198
   PubMedGoogle Scholar
• Triplett D. A., Brandt J. T., Musgrave K. A., Orr C. A. The relationship between lupus anticoagulant and antibodies to phospholipid. JAMA 1988; 259: 550–554
   PubMed Web of Science ®Google Scholar
• Bessman J. D. Epitopes in medicine. The example of lupus anticoagulant. JAMA 1988; 259: 573
   PubMedGoogle Scholar
• Gleicher N., Harlow L., El-Roeiy A. The correlation between lupus anticoagulant and autoantibodies. Mt. Sinai J Med 1992; 59: 32–37
   PubMedGoogle Scholar
• Alving B. M., Baker C. S. Association of IgG cardiolipin antibody with thrombosis in patients with lupus anticoagulant; abstracted. Blood 1987; 70(suppl 1)366A
   Google Scholar
• Feinstein D. I., Rapaport S. I. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1982; 1: 75–95
   Google Scholar
• Nilsson I. M., Astedt B., Hedner U., Berezin D. Intrauterine death and circulating anticoagulant (“antithrombo-plastin”). Acta Med Scand 1975; 197: 153–159
   PubMedGoogle Scholar
• Harris E. N., Gharavi A. E., Boey M. L., Patel B. M., Mackworthy-Young C. G., Loizou S., Hughes G. R.V. Anticar-diolipin antibodies: detection by radioimmunoassay and association with thrombosis in system lupus erythematosus. Lancet 1983; 2: 1211–1214
   PubMed Web of Science ®Google Scholar
• Loizou S., McCrea J. D., Rudge A. C., Reynolds R., Boyle C. C., Harris E. N. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunoabsorbent assay (ELISA): standardization and quantification of results. Clin Exp Immunol 1985; 62: 738–745
   PubMed Web of Science ®Google Scholar
• Thiagarajan P., Shapiro S., de Marco L. Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity. J Clin Invest 1980; 66: 397–405
   PubMed Web of Science ®Google Scholar
• Rote N. S., Dostal-Johnson D., Branch D. W. Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol 1990; 163: 575–584
   PubMed Web of Science ®Google Scholar
• Meyer O., Cyna L., Bourgeois P., Kahn M. F., Ryckewaert A. Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis. Clin Rheumatol 1987; 6: 369–377
   PubMed Web of Science ®Google Scholar
• Schoenfeld Y., Rauch J., Massicotte H., et al. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med 1983; 308: 414–420
   PubMed Web of Science ®Google Scholar
• Harris E. N., Gharavi A. E., Loizou S., et al. Cross reactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985; 16: 1–6
   PubMedGoogle Scholar
• Rauch J., Meng Q. H., Tannenbaum H. Lupus anticoagulant and antiplatelet properties of human hybridoma autoanti-bodies. J Immunol 1987; 139: 2598–2604
   PubMedGoogle Scholar
• Bakimer R., Fishman P., Blank M., Sredni B., Djaldetti M., Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunizing with human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89: 1158–1563
   Google Scholar
• Gleicher N., Harlow L., Dudkiewicz A. A mouse model for the reproductive autoimmune failure syndrome (RAFS). I. Immunization with phospholipid antigens. I.I. Effects on fertility. I.I.I. The response to pregnancy. Am J Reprod Immunol 1989; 19: 80–81
   Google Scholar
• Lockshin M. D., Druzin M. L., Goei S., Qamar T., Magid M. S., Jovanovic L., Ferenc M. Antibody of cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152–156
   PubMed Web of Science ®Google Scholar
• Lockshin M. D., Druzin M. L., Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160: 439–443
   PubMed Web of Science ®Google Scholar
• Gleicher N., El-Roeiy A. A Autoantibody profiles in normal females and males. Proceedings of The Annual Meeting of The Society for Gynecologic Investigation, Salt Lake City, Utah, September, 20–211988, 97, Abstract 76
   Google Scholar
• El-Roeiy A., Myers S. A., Gleicher N. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet Gynecol 1990; 75: 390–396
   PubMed Web of Science ®Google Scholar
• Mackworth-Young C., Chan J., Harris N., et al. High incidence of anti-cardiolipin antibodies in relatives of patients with S.L.E. J Rheumatol 1987; 14: 723–726
   PubMedGoogle Scholar
• Moulias R., Proust J., Wang A., et al. Age related increase in autoantibodies. Lancet 1984; 1: 1178–1129
   PubMedGoogle Scholar
• Parazzini F., Acaia B., Faden D., Lovotti M., Marelli G., Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991; 77: 854–858
   PubMed Web of Science ®Google Scholar
• Infante-Rivard, David M., Gauthier R., Etienne-Rivard G. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med 1991; 325: 1063–1066
   PubMedGoogle Scholar
• Pratt D., Novotny M., Kaberlein G., Dudkiewicz A., Gleicher N. Antithyroid-antibodies and the association with nonorganspecific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 1993; 168: 837–841
   PubMed Web of Science ®Google Scholar
• Cowchock S., Smith J. B., Bocial B. Antibodies to phospho-lipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986; 155: 1002–1010
   PubMed Web of Science ®Google Scholar
• Out H. J., Bruinse H. W., Derksen R. H. W. M. Antiphospholipid antibodies and pregnancy loss. Human Reproduction 1991; 6: 889–897
   PubMedGoogle Scholar
• Triplett D. A., Harris E. N. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1989; 21: 123–131
   PubMed Web of Science ®Google Scholar
• Reece E. A., Gabrielli S., Cullen M. T., Zheng X. Z., Hobbins J. C., Harris E. N. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990; 163: 162–169
   PubMed Web of Science ®Google Scholar
• Cowchock F. S., Reece E. A., Balaban D., Branch D. W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318–1323
   PubMed Web of Science ®Google Scholar
• Peaceman A. M., Silver R. K., MacGregor S. N., Socol M. L. Interlaboratory variation in antiphospholipid antibody testing. Am J Obstet Gynecol 1992; 166: 1780–1787
   PubMed Web of Science ®Google Scholar
• Wapner R. J., Cowchock S., Shapiro S. S. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161: 1271–1272
   PubMed Web of Science ®Google Scholar
• Branch D. W., Dudley D. J., Mitchell M. D., Creighton K. A., Abbott T. M., Hammond E. H., Daynes R. A. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163: 210–216
   PubMed Web of Science ®Google Scholar
• Dudley D. J., Mitchell M. D., Branch D. W. Pathophysiology of antiphospholipid antibodies: Absence of prostaglandin-mediated effect on cultured endothelium. Am J Obstet Gynecol 1990; 162: 953–959
   PubMedGoogle Scholar
• Harris E. N., Gharavi C. G., Mackworth-Young C. G., Patel B. M., Derue A., Hughes G. R.V. Lupoid sclerosis: a possible pathogenic role for antiphospholipid antibodies. Annals Rheum Dis 1985; 44: 281–283
   PubMedGoogle Scholar
• Bringley P. J., Hoffbrand B. I. Antiphospholipid antibody syndrome: a review. J R Soc Med 1987; 80: 445–448
   PubMedGoogle Scholar
• Asherson R. A., Khamashta M. A., Gil A., et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391–399
   PubMed Web of Science ®Google Scholar
• Hughes G. R., Harrisen, Gharavi A. E. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486–489
   PubMed Web of Science ®Google Scholar
• Case 11–1990. N Engl J Med 1990; 322: 754–769
   PubMedGoogle Scholar
• Lafer E. M., Rauch J., Andrzejewski C., Jr, Mudd D., Furie B., Schwartz R., Stollar B. D. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 1981; 153: 897–909
   PubMed Web of Science ®Google Scholar
• Janoff A. S., Rauch J. The structural specificity of antiphospholipid antibodies in autoimmune disease. Chem Phys Lipids 1986; 40: 315–320
   PubMedGoogle Scholar
• Petri M., Bolbus M., Andersen R., Whiting-O'Keefe Q., Corash L., Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987; 30: 601–606
   PubMedGoogle Scholar
• Xu L., Chang V., Murphy A., Rock J. A., Damewood M., Schlaff W., Zacur H. A. Antinuclear antibodies in sera of patients with recurrent pregnancy wastage. Am J Obstet Gynecol 1990; 163: 1493–1497
   PubMed Web of Science ®Google Scholar
• Harger J. H., Rabin B. S., Marchese S. G. The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: A prospective controlled study. Obstet Gynecol 1989; 73: 414–424
   PubMedGoogle Scholar
• Christiansen O. B., Lauritsen J. G., Andersen E. S., Grunnet N. Autoimmune associated recurrent abortions. Human Reproduction 1989; 4: 913–917
   PubMedGoogle Scholar
• Stagnaro-Green A., Roman S. H., Cobin R., El-Harazy E., Alvarez-Margany M., Davies T. F. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264: 1422–1425
   PubMed Web of Science ®Google Scholar
• Glinoer D., Fernandez Soto M., Bourdoux P., Lejeune B., Delange F., Lettone M., Kinthaert J., Robijn C., Grujn J. P., Denayer P. Pregnancy in patients with mild thyroid abnormalities: Maternal and neonatal repercussions. J Clin Endocrinal Metab 1991; 73: 421–427
   PubMed Web of Science ®Google Scholar
• Magaro M., Zoli A., Actomonte L., Mirone L., Lasala L., Barini A., Scuderi F. The association of silent thyroiditis with active system lupus erythematosus. Clin Experiment Rheumatol 1992; 10: 67–70
   PubMed Web of Science ®Google Scholar
• Coulam C. B., Stern J. J. Immunology of ovarian failure. Am J Reprod Immunol 1991; 25: 1–6
   PubMedGoogle Scholar
• Cohen I., Speroff L. Premature ovarian failure: Update. Obstet Gynecol Surv 1991; 46: 156–162
   PubMedGoogle Scholar
• Cowchock F. S., McCabe J. L., Montgomery B. B. Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol 1988; 158: 118–119
   PubMedGoogle Scholar
• Mathur S., Chihal H. J., Horam R. J., Garza D. E., Rust P. F., Williamson H. O. Endometrial antigens involved in the autoimmunity of endometriosis. Fertil Seril 1988; 50: 860–865
   PubMedGoogle Scholar
• Rajkumar K., Malliah V., Simpson C. W. Identifying the presence of antibodies against endometrial antigens. A preliminary study. J Reprod Med 1992; 37: 552–556
   PubMedGoogle Scholar
• Luborsky J. L., Visintin I., Boyers S., Ajari T., Caldwell B., DeCherney A. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990; 70: 65–74
   Google Scholar
• Mathur P., Peress M. R., Williamson H. O., Youmans C. D., Maney S. A., Garvin A. J., Rust P. F., Fudenberg H. H. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 1982; 50: 259–265
   PubMed Web of Science ®Google Scholar
• Barbarino-Monnier P., Gobert G., Guillet-Rosso F., Bene M. C., Landes P., Faure G. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril 1991; 56: 928–932
   PubMed Web of Science ®Google Scholar
• Gleicher N., El-Roeiy A. The reproductive autoimmune failure syndrome (RAFS). Am J Obstet Gynecol 1988; 159: 223–227
   PubMed Web of Science ®Google Scholar
• Harris E. N., Hughes G. R.V. Standardizing the anticardiolipin antibody test. Lancet 1987; 1: 277
   PubMedGoogle Scholar
• Harris E. N., Chan J. K. H., Ashersed R. A., Aber V. R., Gharavi A. E., Hughes G. R.V. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153–2156
   PubMedGoogle Scholar
• Boue F., Dreyfus M., Bridey F., Delfraissy J. F., Dormont J., Tchernia G. Lupus anticoagulant and HIV infection: A prospective study. AIDS 1990; 4: 467–468
   PubMedGoogle Scholar
• MacLean C., Flegg P. J., Kilpatrick D. C. Anti-cardiolipin antibodies and HIV infection. Clin Exp Immunol 1990; 81: 263–266
   PubMed Web of Science ®Google Scholar
• Tadmor B., Putterman C., Naparstek Y. Embryonal permlayer antigens: target for autoimmunity. Lancet 1992; 339: 975–978
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., et al. The 1982revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 127–132
   Google Scholar
• Thorp J. A., Walsh S. W., Brath P. C. Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries. Am J Obstet Gynecol 1988; 159: 1381–1384
   PubMed Web of Science ®Google Scholar
• Nelson D. M., Walsh S. W. Aspirin differently affects thromboxane and prostacyclin production by trophosblast and villous core compartments of human placental villi. Am J Obstet Gynecol 1989; 161: 1593–1598
   PubMedGoogle Scholar
• Schiff E., Peleg E., Goldenberg M., Rosenthal T., Ruppin E., Tamarkin M., Barkai G., Ben-Baruch G., Yahal I., Blankstein J., Goldman B., Meshiach S. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351–356
   PubMed Web of Science ®Google Scholar
• Mills J. A. Aspirin, the ageless remedy?. N Engl J Med 1991; 325: 1303–1304
   PubMedGoogle Scholar
• Clarke R. J., Majo G., Price P., Fitzgerald G. A. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 1991; 325: 1137–1141
   PubMed Web of Science ®Google Scholar
• Lechner K. Lupus anticoagulants and thrombosis. Thrombosis and Haemostasis, M. Verstrete, J. Vermylen, R. Linjner, J. Arnout. Leuven University Press, Belgium 1987; 525–547
   Google Scholar
• DeWolf F., Carreras L. O., Moerman P., Vermylen P., Van Assche A., Renaer M. Decidual vasculopathy and extensive placental infarction in patients with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829–834
   PubMed Web of Science ®Google Scholar
• Gardlund B. The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. Ada Med Scand 1984; 215: 293–298
   PubMedGoogle Scholar
• Elias M., Elder A. Thromboembolism in patients with the “lupus” type circulating anticoagulant. Arch Intern Med 1984; 144: 510–515
   PubMedGoogle Scholar
• Kitzmiller J. L., Watt N., Driscoll S. G. Decidual arteriopathy in hypertension and diabetes in pregnancy: Immunofluo-rescent studies. Am J Obstet Gynecol 1981; 141: 773–779
   PubMed Web of Science ®Google Scholar
• Robertson W. B., Brosens I., Dixon G. Uteroplacental vascular pathology. Eur J Obstet Gynaecol Reprod Biol 1975; 5: 47–65
   PubMedGoogle Scholar
• Labarrere C. A., Catoggio L. J., Mullen E. G., Althabe O. H. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol 1986; 12: 78–86
   PubMed Web of Science ®Google Scholar
• Carreras L. O., Spitz B., Vermylen J., Van Assche A. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br. J Obstet Gynaecol 1981; 88: 890–894
   PubMedGoogle Scholar
• Vermylen J., Spitz B., Van Assche A. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244–246
   PubMedGoogle Scholar
• Walker T. S., Triplett D. A., Javed N., Musgrave K. Evaluation of lupus anticoagulant: Antiphospholipid antibodies, endothelial associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. Thromb Res 1988; 51: 267–281
   PubMed Web of Science ®Google Scholar
• Hasselaar P., Derksen R. H. W. M., Blokzijl L., DeGroot P. G. Thrombosis associated with antiphospholipid antibodies cannot be explained by effect on endothelial and platelet prostanoid synthesis. Thromb Hemost 1988; 59: 80–85
   PubMed Web of Science ®Google Scholar
• Dudley D. J., Mitchell M. D., Branch D. W. Pathophysiology of antiphospholipid antibodies: absence of prostaglandin-mediated effects on cultured endothelium. Am J Obstet Gynecol 1990; 162: 953–959
   PubMedGoogle Scholar
• Alacron-Segovia D. Pathogenetic potential of antiphospholipid antibodies. J. Rheumatol 1988; 15: 890–893
   PubMedGoogle Scholar
• Branch D. W., Dudley D. J., Mitchell M. D., Creighton K. A., Abbott T. M., Hammond E. H., Daynes R. A. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163: 210–216
   PubMed Web of Science ®Google Scholar
• Parke A. L. Systemic lupus erythematosus, connective tissue disorders, and the vasculitides. Principles and Practice of Medical Therapy in Pregnancy2nd ed., N. Gleicher. Appleton & Lange. 1992; 421–428
   Google Scholar
• Kwak H. Y. H., Gilman-Sachs A., Beaman K. D., Beer A. E. Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune cases: Preconception versus postconception treatment. Am J Obstet Gynecol 1992; 166: 1787–1798
   PubMedGoogle Scholar
• Mackworth-Young C. G., David J., Morgan S. H., et al. A double blind placebo controlled trial of intravenous meth-ylprednisolone in systemic lupus erythematosus. Am Rheum Dis 1988; 47: 496–502
   Google Scholar
• El-Roeiy A., Dmowski P., Gleicher N., Radwanska E., Harlow L., Binor Z., Tommon I., Rawlins R. G. Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fertil Steril 1988; 50: 864–871
   PubMed Web of Science ®Google Scholar
• Ahn Y. S., Harrington W. J., Simon S. R., et al. Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 1983; 308: 1396–1399
   PubMed Web of Science ®Google Scholar
• Shumak K. H., Rock G. A. Therapeutic plasma exchange. N Engl J Med 1984; 310: 767–771
   Google Scholar
• Dwyer J. M. Manipulating the immune system with immunoglobulin. N Engl J Med 1992; 326: 107–116
   PubMed Web of Science ®Google Scholar
• Cowchock F. S., Rece E. A., Balaban D., Branch D. W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318–1323
   PubMed Web of Science ®Google Scholar
• Gatenby P. A., Cameron K., Shearman R. P. Pregnancy loss with phospholipid antibodies: Improved outcome with aspirin containing treatment. Aust NZ J Obstet Gynaecol 1989; 29: 294–298
   PubMed Web of Science ®Google Scholar
• Uzan S., Beufils M., Breart G., Bazin B., Capitant C., Paris J. Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 1991; 337: 1427–1431
   PubMed Web of Science ®Google Scholar
• Imperiale T. F., Stollenwerk Petrulis A. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induce hypertensive disease. JAMA 1991; 266: 261–265
   Web of Science ®Google Scholar
• Rosove M. H., Tabsh K., Wasserstrum N., Howard P., Hahn B. H., Kalunian K. C. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630–634
   PubMed Web of Science ®Google Scholar
• Greensppon J. S., Buchanan D. Fetal distress associated with anticardiolipin antibody and a history of intrauterine fetal demise. J Reprod Med 1989; 34: 311–314
   PubMedGoogle Scholar
• Christiansen O. B., Christinsen B. S., Husth M., Mathiesen O., Lauritsen J. G., Grunnet N. Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertil Steril 1992; 58: 328–334
   PubMedGoogle Scholar
• Stirrat G. M. Recurrent spontaneous abortion. Immunological Obstetrics, C. B. Coulam, W. Page Faulk, J. A. McIntyre. Norton Medical Books. 1992; 357–376
   Google Scholar
• de Swiet M., Dorrington P. W., Fidler J., Horsman A., Katz D., Letsky G., Peacock M., Wise P. H. Prolonged heparin therapy in pregnancy causes bone demineralization. Brit J Obstet Gynaecol 1983; 90: 1129–1134
   PubMedGoogle Scholar
• Bonnar J., Redman C. W. G., Sheppard B. L. Treatment of fetal growth retardation in utero with heparin and dipyramidole. Eur J Obstet Gynecol Reprod Biol 1975; 5: 123–134
   PubMedGoogle Scholar
• Sacher R. A., King J. C. Intravenous gammaglobulin in pregnancy: A review. Obstet Gynecol Sun 1988; 44: 25–35
   Google Scholar
• NIH Consensus Conference: Intravenous Immunoglobulin: Prevention and treatment of disease. JAMA 1990; 264: 3189–3193
   PubMed Web of Science ®Google Scholar
• Mueller-Eckhardt G., Heine O., Neppert J., et al. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin. Vox Sang 1989; 56: 151–154
   PubMedGoogle Scholar
• Parke A., Maier D., Wilson D., Andreoli J., Ballow M. Intravenous gammaglobulin, antiphospholipid antibodies, and pregnancy. Ann Intern Med, 110: 495–496
   PubMedGoogle Scholar
• Carreras L. O., Perez G. N., Vega H. R., Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 2: 393
   PubMed Web of Science ®Google Scholar
• Mueller-Eckhardt G., Heine O., Pollen B. IVIG to prevent recurrent spontaneous abortion. Lancet 1991; 337: 424
   PubMedGoogle Scholar
• Christiansen O. B., Mathiesen O., Lauritsen J. G., Grunnet N. Intravenous immunoglobulin treatment of women with multiple miscarriages. Human Reproduction 1992; 7: 718–722
   PubMedGoogle Scholar
• Orvietto R., Achiron A., Ben-Rafael Z., Achiron R. Intravenous immunoglobulin treatment for recurrent abortion caused by antiphospholipid antibodies. Fertil Steril 1991; 56: 1013–1020
   PubMedGoogle Scholar
• Editorial 1992; Obstet Gynecol Surv 1992; 47: 128–128
   Google Scholar
• Gleicher N. Endometriosis: a new approach is needed. Human Reproduction 1992; 7: 821–824
   PubMedGoogle Scholar
• Hill J. A. Immunology and endometriosis. Fertil Steril 1992; 58: 262–264
   PubMedGoogle Scholar
• Groll M. Endometriosis and spontaneous abortion. Fertil Steril 1984; 111: 993–995
   Google Scholar
• Wheeler J. M., Johnston B. M., Malinak L. R. The relationship of endometriosis to spontaneous abortion. Fertil Steril 1983; 39: 656–660
   PubMed Web of Science ®Google Scholar
• Metzger D. A., Oliver D. L., Stohs G. F., Franklin R. R. Association of endometriosis and spontaneous abortion: Effect of control group selection. Fertil Steril 1986; 45: 18–22
   PubMed Web of Science ®Google Scholar
• Grimes D. A., Lebelt S. A., Grimes K. R., Wingo P. A. Systemic lupus erythematosus and reproductive function. A case control study. Am J Obstet Gynecol 1985; 153: 179–187
   PubMedGoogle Scholar
• Mathur S., Peres M. R., Williamson H. O., Youmans C. D., Maney S. A., Garvin A. J., Rust P. F., Fundenberg N. H. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 1982; 50: 259–266
   PubMed Web of Science ®Google Scholar
• Agnello V., Pariser K., Gell J., Gelfand J., Turkoy R. N. Preliminary observations on danazol therapy of systemic lupus erythematosus: effect on DNA antibodies, thrombo-cytopenia and complement. J Rheumatol 1983; 10: 682–687
   PubMed Web of Science ®Google Scholar
• Steinleitner A., Lambert H., Suarez M., Serpat N., Robin B., Cantor B. Periovulatory calcium channel blockade enhances reproductive performance in an animal model for endometriosis-associated subfertility. Am J Obstet Gynecol 1991; 164: 949–952
   PubMedGoogle Scholar
• Steinleitner A., Lambert H., Suarez M., Serpat N., Roy S. Immunomodulation in the treatment of endometriosis-associated subfertility: use of pentoxifylline to reverse the inhibition of fertilization by surgically induced endometriosis in a rodent model. Fertil Steril 1991; 56: 975–979
   PubMed Web of Science ®Google Scholar
• Jansen R. P., Russel P. Nonpigmented endometriosis: clinical, laparoscopic and pathologic definition. Am J Obstet Gynecol 1986; 155: 1154–1160
   PubMed Web of Science ®Google Scholar
• Murphy A. A., Green W. R., Bobie D., de la Cruz Z. C., Rock J. A. Unsuspected endometriosis documented by scanning electron microscopy in visually normal peritoneum. Fertil Steril 1986; 46: 522–529
   PubMed Web of Science ®Google Scholar
• Hill J. A., Andersen D. J. Lymphocyte activity in the presence of peritoneal fluid from fertile women with and without endometriosis. Am J Obstet Gynecol 1989; 161: 861–964
   PubMedGoogle Scholar
• El-Roeiy A., Friberg J., Valessini G., Shoenfeld Y., Kennedy R. C., Gleicher N. The presence of autoantibodies and common idiotypes in sera and seminal plasma of patients with anti-sperm antibodies. Am J Reprod Immunol Microbiol 1987; 14: 4, (abstract)
   Google Scholar
• Saling P. M., Irons G., Waibel R. Mouse sperm antigens that participate in fertilization. Inhibition of sperm fusion with the egg plasma membrane using monoclonal antibodies. Biol Reprod 1985; 33: 515–526
   PubMedGoogle Scholar
• Confino E., Friberg J., Dudkiewicz A. B., Gleicher N. Intrauterine inseminations with washed human spermatozoa. Fertil Steril 1986; 46: 55–60
   PubMed Web of Science ®Google Scholar
• Gleicher N., Boler L., Norusis M., Del Granado A. Hypertensive disease of pregnancy and parity. Am J Obstei Gynecol 1986; 154: 1044–1049
   PubMed Web of Science ®Google Scholar
• Wallenburg H. C. S., Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low dose aspirin and dipyridamole. Am J Obstet Gynecol 1987; 157: 1230–1235
   PubMed Web of Science ®Google Scholar
• Trudinger B. J., Cook C. M., Thomson R. S., Giles W. B., Connelly A. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. Am J Obstet Gynecol 1988; 159: 681–685
   PubMed Web of Science ®Google Scholar
• Flescher E., Fossum D., Gray P. J., Fernandes G., Harper M. J. K., Talal N. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations. J Immunol 1991; 146: 2553–2559
   PubMed Web of Science ®Google Scholar
• Lockwood C. J., Romero R., Feinberg R. F., Clyne L. P., Coster B., Bobbins J. C. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369–373
   PubMed Web of Science ®Google Scholar
• Wallenburg H. C. S., Dekker C. A., Makovitz J. W., Rotmans P. Low dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primi-gravidae. Lancet 1986; 1: 1–3
   PubMed Web of Science ®Google Scholar
• Nelson L. M., Kimzey L. M., White B. J., Merriam G. R. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril 1992; 57: 50–55
   PubMed Web of Science ®Google Scholar
• Cha K., Yoon S., Ko J., et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycle, their culture in vitro and their transfer according to the donor oocyte program. Proceedings of the 45th Annual Meeting of the American Fertility Society, San Francisco, California, November, 13–161989
   Google Scholar
• Hedfors E., Lindahl G., Lindblad S. Anticardiolipin antibodies during pregnancy. J. Rheumatol 1987; 14: 160–165
   PubMedGoogle Scholar
• Khamashta M. A., Gil A., Ancioniex B., et al. Chorea in systemic lupus erythematosus. Association with antiphospholipid antibodies. Ann Rheumatol 1988; 47: 541–546
   Google Scholar
• Adashi E. Y. The potential revelance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series. Endocrine Review 1990; 11: 454–464
   PubMed Web of Science ®Google Scholar
• Gleicher N., Liu H. -C., Dudkiewicz A., Rosenwaks Z., Kaberlein G., Pratt D., Karande V. Antibody profiles as predictors of IVF success. Proceedings of the 48th Anunal Meeting of the American Tertilty Society, New Oreans, Lousiana, November, 2–51992
   Google Scholar
• Fisch B., Rikover Y., Shohat L., Zurgil N., Tadir Y., Ovadia J., Witz I. P., Yron I. The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid autoantibodies. Fertil Steril 1991; 56: 718–724
   PubMed Web of Science ®Google Scholar
• Estes D., Larson D. I. SLE and pregnancy. Clin Obstet Gynecol 1965; 8: 307–321
   Google Scholar
• Fraga A., Mintz G., Orozco J. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J. Rheumatol 1974; 1: 293–298
   Web of Science ®Google Scholar
• Nelson J. L., Koepsell T. D., Dugowson C. E., Voigt L. F., Darling J. R., Haivsen J. A. Fecundity before disease outset in women with rheuniatoid arthritis. Arthritis & Rheumat 1993; 37: 7–14
   Google Scholar
• Pregnancy, Autoimmunity and Connective Tissue Disorders, J. S. Scott, H. A. Bird. Oxford Medical Publications, Oxford University Press. 1990
   Google Scholar
• Scott J. S. Immunological diseases and pregnancy. Brit Med J 1966; 1: 1559–1567
   PubMed Web of Science ®Google Scholar
• Frick P. G. Acquired circulating anticoagulants in systemic collagen disease. Blood 1955; 10: 691–695
   PubMedGoogle Scholar
• Lubbe W. F., Liggins G. C. Role of lupus anticoagulant and autoimmunity in recurrent pregnancy loss. Semin Reprod Endocrin 1988; 6: 181–189
   Google Scholar
• Qamar T., Lockshin M., Druzin M., et al. Antibody to cardiolipin and to RO/LA (SSA/SSB) antigens in maternal-cord serum pairs. Arthritis Rheum 1986; 29: 596–601
   Google Scholar
• Triplett D. A. Obsterical complications associated with antiphospholipid antibodies. Immunological Obstetrics, C. B. Coulam, W. Page Faulk, J. A. McIntyre. Norton Medical Books. 1991; 377–403
   Google Scholar
• Finazzi G., Cortelazzo S., Viero P., Galli M., Barbui T. Maternal lupus anticoagulant and fatal neonatal thrombosis. Thromb Haemost 1987; 47: 238
   Google Scholar
• Sheridan-Pereira M., Pornco R. P., Hays T., Burke M. S. Neonatal aortic thrombosis associated with the lupus anticoagulant. Obstet Gynecol 1988; 71: 1016–1018
   PubMedGoogle Scholar
• El-Roeiy A., Gleicher N., Isenberg D., Kennedy R. C., Shoenfeld Y. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus. Clin Exp Immunol 1987; 68: 528–534
   PubMedGoogle Scholar
• Scott J. S., Maddison P. J., Taylor P. V., Esscher E., Scott O., Skinner R. P. Connective tissue disease, antibodies to ribo-nucleoprotein and congenital heart block. N Engl J Med 1983; 309: 209–212
   PubMed Web of Science ®Google Scholar
• Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069–3073
   PubMed Web of Science ®Google Scholar
• Cowchock S., Fort J., Munoz S., Norberg R., Maddrey W. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol 1988; 73: 289–294
   PubMedGoogle Scholar
• Matsura E., Igarashi Y., Fujimoto M., Ichikawa K., Suzuki T., Sumida T., Yasuda T., Koike T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol 1992; 148: 3885–3891
   PubMed Web of Science ®Google Scholar
• Galli M., Comfurius P., Maassen C., Hemker H. C., DeBaets M. H., van Breda-Briesman P. J. C., Barbui T., Zwaal R. F. A., Bevers E. M. Anticardiolipin antibodies (ACA) directed not to cardiolipin but top a plasma protein cofactor. Lancet 1990; 335: 1544–1547
   PubMed Web of Science ®Google Scholar